Key Advantages

Share

Our pipeline include antibodies addressing two receptors, progressing into pre clinical stage:

Immune Oncology

Clinical Indications:
Metastatic melanoma

Immune Oncology

Clinical Indications:
Metastatic melanoma, Metastatic lung cancer

Immune Oncology

Immune Oncology

Immune Oncology

  • High certainty and fast antibody generation of targeted-specific antibodies (months vs many years)
  • Selective blocking of a single target among closely related ensemble of targets, which allows:
    • Specific and exclusive blocking of ligand/receptor binding domain, aiming to increase response rate among patients
    • Eliminating binding of conflicting ligands/receptors such as inhibitory versus activatory modulators typical to immune checkpoint functions

 

 

 

 

© Copyright 2015, Tikcro Ltd. | Legal - Terms of use | All rights reserved | Site by Imaginet